Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-031842
Filing Date
2018-05-21
Accepted
2018-05-21 16:22:01
Documents
1
Period of Report
2018-05-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3910
  Complete submission text file 0001209191-18-031842.txt   5231
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Issuer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 128 SPRING STREET, SUITE 520 LEXINGTON MA 02421
Business Address
Goldberg Mark Alan (Reporting) CIK: 0001532475 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36177 | Film No.: 18849889